In the week of February 17, 2026, 28 holders filed a new Schedule 13D and 403 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is KW Kingfisher LLC's 100% of Sotherly Hotels Inc. (Schedule 13D, February 20, 2026).
New 13D28
New 13G403
Stated intents0
The week of 2026-02-17, 28 holders filed a new Schedule 13D and 403 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-20 | Sotherly Hotels Inc. | KW Kingfisher LLC | 100% | SCHEDULE 13D |
| 2026-02-18 | Evolution Metals & Technologies Corp. | The Zeus Trust, UA dated April 15, 2025 | 70.18% | SCHEDULE 13D |
| 2026-02-17 | Docebo Inc. | Jason Chapnik | 56.7% | SCHEDULE 13D |
| 2026-02-17 | M2i Global, Inc. | Executive Real Estate LLC | 45.25% | SCHEDULE 13D |
| 2026-02-19 | United Acquisition Corp. I | United Acquisition SPAC LLC | 27.3% | SCHEDULE 13D |
| 2026-02-18 | Space Asset Acquisition Corp. | Space Asset Acquisition Sponsor LLC | 25.48% | SCHEDULE 13D |
| 2026-02-20 | Columbus Circle Capital Corp II | Columbus Circle 2 Sponsor Corporation LLC | 25.3% | SCHEDULE 13D |
| 2026-02-18 | Boxlight Corp | Khan MD Ehsan | 24.3% | SCHEDULE 13D |
| 2026-02-17 | Spyglass Pharma, Inc. | RA Capital Management, L.P. | 24.1% | SCHEDULE 13D |
| 2026-02-20 | DNA X, Inc. | DNA Holdings Venture Inc. | 19.9% | SCHEDULE 13D |
| 2026-02-17 | Investcorp Europe Acquisition Corp I | Meteora Capital, LLC | 18.78% | SCHEDULE 13D |
| 2026-02-17 | Agomab Therapeutics NV | LSP 7 Cooperatieve U.A. | 10.6% | SCHEDULE 13D |
| 2026-02-20 | Immunic, Inc. | Biotechnology Value Fund L P | 9.99% | SCHEDULE 13D |
| 2026-02-19 | Funko, Inc. | Fund 1 Investments, LLC | 9.96% | SCHEDULE 13D |
| 2026-02-18 | Infleqtion, Inc. | Maverick Capital, Ltd. | 9.2% | SCHEDULE 13D |
| 2026-02-19 | Phreesia, Inc. | Pale Fire Capital SE | 9.2% | SCHEDULE 13D |
| 2026-02-18 | Angi Inc. | Pale Fire Capital SE | 8.3% | SCHEDULE 13D |
| 2026-02-19 | SCI Engineered Materials, Inc. | Charles Kohnen | 8.12% | SCHEDULE 13D |
| 2026-02-18 | Innventure, Inc. | Ascent Capital Partners LLC | 6.7% | SCHEDULE 13D |
| 2026-02-18 | Scholastic Corp | Iole Lucchese | 5.5% | SCHEDULE 13D |
| 2026-02-17 | Innventure, Inc. | Commonwealth Asset Management LP | 5.3% | SCHEDULE 13D |
| 2026-02-17 | Radcom Ltd | Value Base Ltd. | 5.27% | SCHEDULE 13D |
| 2026-02-18 | Natural Health Trends Corp | Sharng Chris Tahjiun | 5.2% | SCHEDULE 13D |
| 2026-02-20 | Huntsman Corp | Peter R. Huntsman | 5.09% | SCHEDULE 13D |
| 2026-02-20 | enVVeno Medical Corp | Northstrive Fund II LP | 5.05% | SCHEDULE 13D |
| 2026-02-20 | enVVeno Medical Corp | Braeden Lichti | 5.05% | SCHEDULE 13D |
| 2026-02-18 | Urban Outfitters | David A. Hayne | 5.04% | SCHEDULE 13D |
| 2026-02-18 | GSI Technology, Inc. | Galloway Capital Partners, LLC | 5.02% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-18 | Partners Group Lending Fund, LLC | Australian Retirement Trust Pty Ltd | 90.91% | SCHEDULE 13G |
| 2026-02-17 | TGE Value Creative Solutions Corp. | TGE SpiderNet Capital Group LLC | 87.5% | SCHEDULE 13G |
| 2026-02-17 | Crestline Lending Solutions, LLC | Partners Capital Holdings, LLP | 85% | SCHEDULE 13G |
| 2026-02-17 | The Generation Essentials Group | AMTD Group Inc. | 77.9% | SCHEDULE 13G |
| 2026-02-17 | Range Acquisition Corp. | Mark N. Tompkins | 75% | SCHEDULE 13G |
| 2026-02-17 | Primus Acquisition Inc. | Mark N. Tompkins | 75% | SCHEDULE 13G |
| 2026-02-17 | Fast Track Group | Lim Sin Foo, Harris | 53.15% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Jeremy Simmons Spivey | 45% | SCHEDULE 13G |
| 2026-02-17 | BGIN BLOCKCHAIN Ltd | Qiuhua Li | 41.93% | SCHEDULE 13G |
| 2026-02-17 | JM Group Ltd | Chun Kwok Stanley Ting | 41.3% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Michael Bruce Rowe, Jr. | 29% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Erik Daniel West | 29% | SCHEDULE 13G |
| 2026-02-17 | Copley Acquisition Corp | Copley Acquisition Sponsors, LLC | 26.57% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | New America Sponsor I LLC | 26.31% | SCHEDULE 13G |
| 2026-02-17 | Vine Hill Capital Investment Corp. II | Vine Hill Capital Sponsor II LLC | 25% | SCHEDULE 13G |
| 2026-02-17 | Range Acquisition Corp. | Ian Jacobs | 25% | SCHEDULE 13G |
| 2026-02-17 | Primus Acquisition Inc. | Ian Jacobs | 25% | SCHEDULE 13G |
| 2026-02-18 | Galata Acquisition Corp. Ii | Galata Acquisition Sponsor II, LLC | 25% | SCHEDULE 13G |
| 2026-02-17 | Regentis Biomaterials Ltd. | Dr. Ehud Geller | 23.2% | SCHEDULE 13G |
| 2026-02-17 | Karbon Capital Partners Corp. | Karbon Capital Partners Core Holdings, LLC | 21.6% | SCHEDULE 13G |
| 2026-02-17 | BGIN BLOCKCHAIN Ltd | Qingfeng Wu | 20.16% | SCHEDULE 13G |
| 2026-02-17 | Liberty Live Holdings, Inc. | Warren E. Buffett | 19.5% | SCHEDULE 13G |
| 2026-02-18 | Ituran Location & Control Ltd | Izzy Sheratzky | 19.44% | SCHEDULE 13G |
| 2026-02-17 | Grupo Aeromexico, S.A.B. de C.V. | Apollo Management Holdings GP, LLC | 18.9% | SCHEDULE 13G |
| 2026-02-17 | Banzai International, Inc. | CP BF Lending, LLC | 18.7% | SCHEDULE 13G |
| 2026-02-19 | Meshflow Acquisition Corp | Meshflow Acquisition Sponsor LLC | 18.7% | SCHEDULE 13G |
| 2026-02-17 | Mntn Inc | Mark Douglas | 17.8% | SCHEDULE 13G |
| 2026-02-17 | Arcos Dorados Holdings Inc | Lazard Asset Management LLC | 16.4% | SCHEDULE 13G |
| 2026-02-17 | Korea Fund Inc | Lazard Asset Management LLC | 13.3% | SCHEDULE 13G |
| 2026-02-17 | Global Indemnity Group, LLC | Essex Equity Joint Investment Vehicle, LLC | 13.27% | SCHEDULE 13G |
| 2026-02-18 | Aurora Mobile Limited | PM Partners I LP | 13.2% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Marc L. Andreessen | 11.7% | SCHEDULE 13G |
| 2026-02-17 | Elauwit Connection, Inc | Maxim Cerith LLC | 11.3% | SCHEDULE 13G |
| 2026-02-17 | Janus Detroit Street Trust | Hennion & Walsh Asset Management, Inc. | 11.3% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | Tiger Global Private Investment Partners X, L.P. | 10.4% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Lightspeed General Partner X, L.P. | 10.1% | SCHEDULE 13G |
| 2026-02-17 | Qt Imaging Holdings, Inc. | Alyeska Investment Group, L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Rekor Systems, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | SOBR Safe, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Virax Biolabs Group Limited | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | VSee Health, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Wearable Devices Ltd. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Edible Garden AG Inc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Glucotrack, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | HCW Biologics Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Imunon, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | INVO Fertility, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Aethlon Medical Inc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Ascent Solar Technologies, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Biodexa Pharmaceuticals Plc | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Bluejay Diagnostics, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Cycurion, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Minerva Neurosciences Inc | Balyasny Asset Management L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | NextCure, Inc. | Ikarian Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Mdjm Ltd | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2026-02-18 | Azora Therapeutics, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-18 | Bluejay Diagnostics, Inc. | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-19 | Iveda Solutions, Inc. | Lind Global Fund III LP | 9.99% | SCHEDULE 13G |
| 2026-02-19 | Our Bond, Inc. | Ascent Partners Fund LLC | 9.99% | SCHEDULE 13G |
| 2026-02-20 | Minerva Neurosciences Inc | Coastlands Capital LP | 9.99% | SCHEDULE 13G |
| 2026-02-20 | Immunic, Inc. | Vivo Opportunity Fund Holdings, L.P. | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Minerva Neurosciences Inc | Logos Global Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Adagio Medical Holdings, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Critical Metals Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Dragonfly Energy Holdings Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Brazil Potash Corp. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | In8bio, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Velo3D, Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Veru Inc. | Alyeska Investment Group, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Blue Water Acquisition Corp. III | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Digital Currency X Technology Inc. | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Kartoon Studios Inc | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | 22nd Century Group | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Dbv Technologies S.A. | MPM BioImpact LLC | 9.9% | SCHEDULE 13G |
| 2026-02-18 | CDT Equity Inc. | Ascent Partners Fund LLC | 9.9% | SCHEDULE 13G |
| 2026-02-19 | Q32 Bio Inc. | Point72 Asset Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-02-19 | La Rosa Holdings Corp. | SZOP Opportunities I LLC | 9.9% | SCHEDULE 13G |
| 2026-02-17 | Worksport Ltd. | Armistice Capital, LLC | 9.84% | SCHEDULE 13G |
| 2026-02-17 | Texas Ventures Acquisition III Corp | Anson Funds Management LP | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Verses AI Inc. | Sorbie Bornholm LP | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Verses AI Inc. | Sorbie Investments Llp | 9.8% | SCHEDULE 13G |
| 2026-02-20 | Ascent Solar Technologies, Inc. | Ryan Taylor | 9.8% | SCHEDULE 13G |
| 2026-02-17 | Palatin Technologies Inc | Driehaus Capital Management LLC | 9.79% | SCHEDULE 13G |
| 2026-02-17 | Babcock & Wilcox Enterprises, Inc. | Hood River Capital Management LLC | 9.58% | SCHEDULE 13G |
| 2026-02-17 | Quoin Pharmaceuticals Ltd. | Woodline Partners LP | 9.5% | SCHEDULE 13G |
| 2026-02-17 | TIC Solutions, Inc. | Alyeska Investment Group, L.P. | 9.47% | SCHEDULE 13G |
| 2026-02-17 | GigCapital7 Corp. | Highbridge Capital Management, LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Sohu.com Ltd | Nomura Asset Management International Inc. | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Acquisition Corp. | Sona Asset Management (Us) LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Urban One, Inc. | Citadel Securities GP LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Foresight Financial Group Inc. | AllianceBernstein L.P. | 9.4% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | DAG Ventures Management IV, LLC | 9.4% | SCHEDULE 13G |
| 2026-02-17 | ADC Therapeutics SA | TCG Crossover GP II, LLC | 9.2% | SCHEDULE 13G |
| 2026-02-17 | Cartesian Growth Corp III | Fort Baker Capital Management LP | 9.2% | SCHEDULE 13G |
| 2026-02-19 | Energous Corp | MYDA Advisors LLC | 9.19% | SCHEDULE 13G |
| 2026-02-17 | Andersen Group Inc | J. Goldman & Co LP | 9.17% | SCHEDULE 13G |
| 2026-02-17 | TuHURA Biosciences, Inc. | Highbridge Capital Management, LLC | 9.1% | SCHEDULE 13G |
| 2026-02-20 | United Acquisition Corp. I | RP Investment Advisors LP | 9.1% | SCHEDULE 13G |
| 2026-02-17 | SR Bancorp Inc | Somerset Regal Bank Employee Stock Ownership Plan Trust | 9% | SCHEDULE 13G |
| 2026-02-17 | New Fortress Energy Inc | Energy Transition Holdings LLC | 9% | SCHEDULE 13G |
| 2026-02-17 | Grupo Aeromexico, S.A.B. de C.V. | Silver Point Capital, L.P. | 9% | SCHEDULE 13G |
| 2026-02-17 | Better Home & Finance Holding Company | Frontier Capital Management Co.,LLC | 8.91% | SCHEDULE 13G |
| 2026-02-17 | FB Bancorp Inc | Fidelity Bank Employee Stock Ownership Plan Trust | 8.8% | SCHEDULE 13G |
| 2026-02-17 | Connect Biopharma Holdings Ltd | Ikarian Capital, LLC | 8.8% | SCHEDULE 13G |
| 2026-02-17 | Pelican Acquisition Corp | Decagon Asset Management LLP | 8.66% | SCHEDULE 13G |
| 2026-02-20 | Q32 Bio Inc. | Opaleye Management Inc. | 8.65% | SCHEDULE 13G |
| 2026-02-17 | Crown Reserve Acquisition Corp. I | Magnetar Financial LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | Anson Funds Management LP | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Schonfeld Strategic Advisors LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Insight Digital Partners II | Polar Asset Management Partners Inc. | 8.6% | SCHEDULE 13G |
| 2026-02-17 | ZOOZ Strategy Ltd. | Newtyn Management, LLC | 8.6% | SCHEDULE 13G |
| 2026-02-17 | Bain Capital GSS Investment Corp. | Empyrean Capital Partners, LP | 8.5% | SCHEDULE 13G |
| 2026-02-18 | Paramount Gold Nevada Corp. | Yuan Fangjian | 8.5% | SCHEDULE 13G |
| 2026-02-17 | Pasithea Therapeutics Corp. | Ameriprise Financial, Inc. | 8.4% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Empyrean Capital Partners, LP | 8.35% | SCHEDULE 13G |
| 2026-02-17 | Fifth District Bancorp Inc | Fifth District Savings Bank Employee Stock Ownership Plan Trust | 8.3% | SCHEDULE 13G |
| 2026-02-17 | ARKO Corp. | CIBC Private Wealth Group LLC | 8.3% | SCHEDULE 13G |
| 2026-02-18 | ARKO Petroleum Corp. | CIBC Private Wealth Group LLC | 8.3% | SCHEDULE 13G |
| 2026-02-17 | Blackrock Muniyield Pennsylvania Quality Fund | Rivernorth Capital Management, LLC | 8.24% | SCHEDULE 13G |
| 2026-02-17 | TON Strategy Company | Aristeia Capital, L.L.C. | 8.21% | SCHEDULE 13G |
| 2026-02-17 | Equity Lifestyle Properties, Inc. | T. Rowe Price Associates, Inc. | 8.2% | SCHEDULE 13G |
| 2026-02-17 | Morgan Stanley India Investment Fund, Inc. | Lazard Asset Management LLC | 8.2% | SCHEDULE 13G |
| 2026-02-17 | 4d Molecular Therapeutics, Inc. | Janus Henderson Group Plc | 8.1% | SCHEDULE 13G |
| 2026-02-20 | Cineverse Corp. | Corsair Capital Management, L.P. | 8.1% | SCHEDULE 13G |
| 2026-02-17 | Rice Acquisition Corp 3 | Oaktree Capital Management, L.P. | 8.02% | SCHEDULE 13G |
| 2026-02-17 | Fast Track Group | LOW Jiayi | 8.02% | SCHEDULE 13G |
| 2026-02-19 | SLR Investment Corp | Thornburg Investment Management | 8.01% | SCHEDULE 13G |
| 2026-02-17 | Alto Neuroscience Inc | Vestal Point Capital, LP | 8% | SCHEDULE 13G |
| 2026-02-17 | Silvia, Inc. | Anson Funds Management LP | 8% | SCHEDULE 13G |
| 2026-02-17 | People Incorporated | Aristeia Capital, L.L.C. | 7.96% | SCHEDULE 13G |
| 2026-02-17 | Bel Fuse Inc-Cl B | T. Rowe Price Associates, Inc. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Merlin, Inc. | Highbridge Capital Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Imax Corp | Nomura Asset Management International Inc. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Social Commerce Partners Corp | Magnetar Financial LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | OnKure Therapeutics, Inc. | ADAR1 Capital Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Contineum Therapeutics, Inc. | Janus Henderson Group Plc | 7.9% | SCHEDULE 13G |
| 2026-02-18 | OKYO Pharma Ltd | Point72 Asset Management, L.P. | 7.9% | SCHEDULE 13G |
| 2026-02-17 | Lion Group Holding Ltd | Marex Financial | 7.8% | SCHEDULE 13G |
| 2026-02-17 | Ultra Clean Holdings Inc | Frontier Capital Management Co.,LLC | 7.73% | SCHEDULE 13G |
| 2026-02-17 | Ribbon Acquisition Corp. | Rivernorth Capital Management, LLC | 7.66% | SCHEDULE 13G |
| 2026-02-17 | Sable Offshore Corp. | Alyeska Investment Group, L.P. | 7.65% | SCHEDULE 13G |
| 2026-02-17 | Shoals Technologies Group, Inc. (Class A) | T. Rowe Price Associates, Inc. | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Hennessy Capital Investment Corp. VII | Highbridge Capital Management, LLC | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Contineum Therapeutics, Inc. | Balyasny Asset Management L.P. | 7.6% | SCHEDULE 13G |
| 2026-02-18 | Sutro Biopharma, Inc. | Bvf Partners L P | 7.6% | SCHEDULE 13G |
| 2026-02-17 | Kestra Medical Technologies | T. Rowe Price Associates, Inc. | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Solid Biosciences Inc. | Vestal Point Capital, LP | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Damora Therapeutics Inc | Jain Global LLC | 7.5% | SCHEDULE 13G |
| 2026-02-18 | Proem Acquisition Corp I | Linden Advisors LP | 7.5% | SCHEDULE 13G |
| 2026-02-17 | Palvella Therapeutics Inc | First Light Asset Management, LLC | 7.49% | SCHEDULE 13G |
| 2026-02-17 | Opus Genetics Inc | Balyasny Asset Management L.P. | 7.41% | SCHEDULE 13G |
| 2026-02-17 | InspireMD, Inc. | Orbimed Advisors LLC | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Acquisition Corp. | LMR Partners LLP | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Karbon Capital Partners Corp. | Empyrean Capital Partners, LP | 7.4% | SCHEDULE 13G |
| 2026-02-17 | Immix Biopharma | Janus Henderson Group Plc | 7.4% | SCHEDULE 13G |
| 2026-02-17 | X4 Pharmaceuticals Inc | Saturn V Capital Management LP | 7.36% | SCHEDULE 13G |
| 2026-02-17 | XPLR Infrastructure, LP | Anchorage Capital Advisors, L.P. | 7.3% | SCHEDULE 13G |
| 2026-02-17 | BillionToOne, Inc. | Oguzhan Atay | 7.3% | SCHEDULE 13G |
| 2026-02-17 | Newbridge Acquisition Ltd | Space Summit Capital LLC | 7.3% | SCHEDULE 13G |
| 2026-02-17 | Titan Mining Corporation | Alyeska Investment Group, L.P. | 7.28% | SCHEDULE 13G |
| 2026-02-17 | Satellogic Inc | Alyeska Investment Group, L.P. | 7.25% | SCHEDULE 13G |
| 2026-02-17 | Sotera Health Co | Sessa Capital GP, LLC | 7.23% | SCHEDULE 13G |
| 2026-02-17 | Cartesian Growth Corp III | Highbridge Capital Management, LLC | 7.2% | SCHEDULE 13G |
| 2026-02-17 | Castle Biosciences Inc | RTW Investments, LP | 7.2% | SCHEDULE 13G |
| 2026-02-17 | ACV Auctions Inc. | Atreides Management, LP | 7.2% | SCHEDULE 13G |
| 2026-02-17 | Cantor Equity Partners II Inc | Alyeska Investment Group, L.P. | 7.17% | SCHEDULE 13G |
| 2026-02-17 | ESS Tech, Inc. | Alyeska Investment Group, L.P. | 7.14% | SCHEDULE 13G |
| 2026-02-17 | ZoomInfo Technologies Inc | Ahmet H. Okumus | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | AllianceBernstein L.P. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | MapLight Therapeutics, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Personalis, Inc. | Ameriprise Financial, Inc. | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Crane Harbor Acquisition Corp. | Polar Asset Management Partners Inc. | 7.1% | SCHEDULE 13G |
| 2026-02-18 | Regional Health Properties, Inc | Radoff Bradley Louis | 7.1% | SCHEDULE 13G |
| 2026-02-17 | Freenome, Inc. | Holocene Advisors, LP | 7.02% | SCHEDULE 13G |
| 2026-02-17 | Immix Biopharma | Saturn V Capital Management LP | 6.97% | SCHEDULE 13G |
| 2026-02-17 | Quoin Pharmaceuticals Ltd. | ADAR1 Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Ovid Therapeutics Inc. | ADAR1 Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | BillionToOne, Inc. | David Tsao | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Jakks Pacific Inc | Gate City Capital Management, LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Greenoaks Capital Partners LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | Abrdn Japan Equity Fund, Inc. | Almitas Capital LLC | 6.9% | SCHEDULE 13G |
| 2026-02-17 | TGE Value Creative Solutions Corp. | Aristeia Capital, L.L.C. | 6.81% | SCHEDULE 13G |
| 2026-02-17 | Bitcoin Infrastructure Acquisition Corp Ltd | Aristeia Capital, L.L.C. | 6.81% | SCHEDULE 13G |
| 2026-02-18 | Beeline Holdings, Inc. | Sansar Capital Master Fund, L.P. | 6.81% | SCHEDULE 13G |
| 2026-02-17 | Jade Biosciences, Inc. | Bellevue Group AG | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Rocky Brands Inc | AllianceBernstein L.P. | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Imperial Petroleum Inc. | Anson Funds Management LP | 6.8% | SCHEDULE 13G |
| 2026-02-17 | Artius II Acquisition Inc. | HGC Investment Management Inc | 6.76% | SCHEDULE 13G |
| 2026-02-17 | Hennessy Capital Investment Corp. VII | Lighthouse Investment Partners, LLC | 6.74% | SCHEDULE 13G |
| 2026-02-18 | SCE Trust V | General Motors Investment Management Corporation | 6.74% | SCHEDULE 13G |
| 2026-02-17 | Celcuity Inc. | Avoro Capital Advisors LLC | 6.72% | SCHEDULE 13G |
| 2026-02-17 | Kornit Digital Ltd. | Disciplined Growth Investors Inc | 6.7% | SCHEDULE 13G |
| 2026-02-17 | Wealthfront Corp | Meyer Malka | 6.7% | SCHEDULE 13G |
| 2026-02-17 | TIC Solutions, Inc. | Gates Capital Management, L.P. | 6.7% | SCHEDULE 13G |
| 2026-02-17 | Definium Therapeutics Inc | Driehaus Capital Management LLC | 6.64% | SCHEDULE 13G |
| 2026-02-17 | BEST SPAC I Acquisition Corp. | Rivernorth Capital Management, LLC | 6.64% | SCHEDULE 13G |
| 2026-02-17 | Westin Acquisition Corp. | Shaolin Capital Management LLC | 6.62% | SCHEDULE 13G |
| 2026-02-18 | Ituran Location & Control Ltd | Yehuda Kahane | 6.62% | SCHEDULE 13G |
| 2026-02-17 | Globa Terra Acquisition Corporation | LMR Partners LLP | 6.6% | SCHEDULE 13G |
| 2026-02-17 | Roman DBDR Acquisition Corp. II | Fort Baker Capital Management LP | 6.6% | SCHEDULE 13G |
| 2026-02-19 | Spartacus Acquisition Corp. II | Harraden Circle Investments, LLC | 6.52% | SCHEDULE 13G |
| 2026-02-17 | Adicet Bio, Inc. | Woodline Partners LP | 6.5% | SCHEDULE 13G |
| 2026-02-17 | Enliven Therapeutics Inc | Vestal Point Capital, LP | 6.5% | SCHEDULE 13G |
| 2026-02-17 | WW International, Inc. | Cooper Creek Partners Management LLC | 6.5% | SCHEDULE 13G |
| 2026-02-17 | Commercial Bancgroup Inc | T. Rowe Price Investment Management, Inc. | 6.5% | SCHEDULE 13G |
| 2026-02-18 | Bicycle Therapeutics plc | Armistice Capital, LLC | 6.48% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Magnetar Financial LLC | 6.44% | SCHEDULE 13G |
| 2026-02-17 | Elme Communities | Highbridge Capital Management, LLC | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Cava Group Inc | AllianceBernstein L.P. | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Xperi Inc. | Clearline Capital LP | 6.4% | SCHEDULE 13G |
| 2026-02-20 | ARKO Petroleum Corp. | CUSHING ASSET MANAGEMENT, LP dba NXG INVESTMENT MANAGEMENT | 6.4% | SCHEDULE 13G |
| 2026-02-17 | Voyager Technologies, Inc. | Alyeska Investment Group, L.P. | 6.35% | SCHEDULE 13G |
| 2026-02-19 | Chimera Investment Corp | Thornburg Investment Management | 6.34% | SCHEDULE 13G |
| 2026-02-17 | Fortive Corp | T. Rowe Price Associates, Inc. | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Keurig Dr Pepper Inc. | Harris Associates L P | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Hyperliquid Strategies Inc | D1 Capital Partners L.P. | 6.3% | SCHEDULE 13G |
| 2026-02-17 | DigitalBridge Group, Inc. | Pentwater Capital Management LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Zai Lab Limited | RTW Investments, LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | Spyglass Pharma, Inc. | Srinivas Akkaraju | 6.3% | SCHEDULE 13G |
| 2026-02-17 | RLJ Lodging Trust | H/2 Credit Manager LP | 6.3% | SCHEDULE 13G |
| 2026-02-17 | FG Merger II Corp. | Rivernorth Capital Management, LLC | 6.24% | SCHEDULE 13G |
| 2026-02-19 | Ventyx Biosciences, Inc. | Glazer Capital, LLC | 6.23% | SCHEDULE 13G |
| 2026-02-17 | Equifax Inc. | Harris Associates L P | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Zimmer Biomet Holdings, Inc. | Harris Associates L P | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Odysseus (Cayman) Ltd | Highbridge Capital Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Jade Biosciences, Inc. | Janus Henderson Group Plc | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Enviri LLC | Newtyn Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-02-17 | MapLight Therapeutics, Inc. | T. Rowe Price Investment Management, Inc. | 6.2% | SCHEDULE 13G |
| 2026-02-17 | Jackson Acquisition Company Ii | HGC Investment Management Inc | 6.19% | SCHEDULE 13G |
| 2026-02-19 | Forrester Research, Inc. | Portolan Capital Management, LLC | 6.12% | SCHEDULE 13G |
| 2026-02-17 | Alkermes Plc | Baker Bros. Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Sound Financial Bancorp Inc | AllianceBernstein L.P. | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Moonlake Immunotherapeutics | Cormorant Asset Management, LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Velos Acquisition I Corp. f/k/a M3-Brigade Acquisition V Corp. | Polar Asset Management Partners Inc. | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Apellis Pharmaceuticals, Inc. | RTW Investments, LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Green Dot Corporation | No Street GP LP | 6.1% | SCHEDULE 13G |
| 2026-02-17 | Uniti Group Inc | T. Rowe Price Investment Management, Inc. | 6.1% | SCHEDULE 13G |
| 2026-02-19 | Lyft Inc | Millennium Management LLC | 6.1% | SCHEDULE 13G |
| 2026-02-18 | European Wax Center, Inc. | Hilary L. Shane | 6.01% | SCHEDULE 13G |
| 2026-02-17 | First Financial Bancorp | Nomura Asset Management International Inc. | 6% | SCHEDULE 13G |
| 2026-02-17 | Fortune Brands Innovations, Inc. | Orbis Investment Management Ltd | 6% | SCHEDULE 13G |
| 2026-02-17 | Ptc Therapeutics, Inc. | Janus Henderson Group Plc | 6% | SCHEDULE 13G |
| 2026-02-17 | Damora Therapeutics Inc | Venrock Healthcare Capital Partners III, L.P. | 6% | SCHEDULE 13G |
| 2026-02-17 | Activate Energy Acquisition | KRYGER CAPITAL Ltd | 6% | SCHEDULE 13G |
| 2026-02-17 | Sonoco Products Co | Fuller & Thaler Asset Management, Inc. | 5.98% | SCHEDULE 13G |
| 2026-02-17 | enGene Holdings Inc. | Cormorant Asset Management, LP | 5.97% | SCHEDULE 13G |
| 2026-02-17 | Nakamoto Inc. | Alyeska Investment Group, L.P. | 5.93% | SCHEDULE 13G |
| 2026-02-17 | TCW Direct Lending VIII LLC | First Trust Capital Management L.P. | 5.93% | SCHEDULE 13G |
| 2026-02-17 | Range Capital Acquisition Corp II | Magnetar Financial LLC | 5.91% | SCHEDULE 13G |
| 2026-02-17 | Willis Towers Watson Public Limited Company | Harris Associates L P | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Dayforce, Inc. | Pentwater Capital Management LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | AA Mission Acquisition Corp. II | Magnetar Financial LLC | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bel Fuse Inc-Cl B | Janus Henderson Group Plc | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Mfs High Yield Municipal Trust | Almitas Capital LLC | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bain Capital GSS Investment Corp. | Fort Baker Capital Management LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Veris Residential, Inc. | H/2 Credit Manager LP | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Procept Biorobotics Corp | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Ryan Specialty Holdings, Inc. | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Bicara Therapeutics Inc | T. Rowe Price Investment Management, Inc. | 5.9% | SCHEDULE 13G |
| 2026-02-17 | Fortuna Mining Corp | Global X Management CO LLC | 5.87% | SCHEDULE 13G |
| 2026-02-17 | Rithm Acquisition Corp. | Empyrean Capital Partners, LP | 5.87% | SCHEDULE 13G |
| 2026-02-19 | XFLH Capital Corporation | Feis Equities LLC | 5.85% | SCHEDULE 13G |
| 2026-02-17 | Louisiana-Pacific Corp | Eminence Capital, LP | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Gibraltar Industries Inc | AllianceBernstein L.P. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Solana Co | Polar Asset Management Partners Inc. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Eastern Bankshares Inc | T. Rowe Price Investment Management, Inc. | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Arts Way Manufacturing Co Inc | Walther Larry M | 5.8% | SCHEDULE 13G |
| 2026-02-19 | Sable Offshore Corp. | FourWorld Capital Management LLC | 5.8% | SCHEDULE 13G |
| 2026-02-17 | Daedalus Special Acquisition Corp. | J. Goldman & Co LP | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Invest Green Acquisition Corp | Magnetar Financial LLC | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Spruce Biosciences, Inc. | Alyeska Investment Group, L.P. | 5.79% | SCHEDULE 13G |
| 2026-02-17 | Energy Fuels Inc | Global X Management CO LLC | 5.75% | SCHEDULE 13G |
| 2026-02-17 | Installed Building Products | T. Rowe Price Associates, Inc. | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Atmus Filtration Technologies Inc | T. Rowe Price Associates, Inc. | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Paycom Software, Inc. | Harris Associates L P | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Adagio Medical Holdings, Inc. | ADAR1 Capital Management, LLC | 5.7% | SCHEDULE 13G |
| 2026-02-17 | IHS Holding Ltd | International Finance Corporation | 5.7% | SCHEDULE 13G |
| 2026-02-17 | BridgeBio Pharma, Inc. | Janus Henderson Group Plc | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Kalaris Therapeutics, Inc. | RTW Investments, LP | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Agricultural & Natural Solutions Acquisition Corporation | Fort Baker Capital Management LP | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Pioneer Floating Rate Fund, Inc. | Almitas Capital LLC | 5.7% | SCHEDULE 13G |
| 2026-02-17 | Perrigo Co Plc | Fuller & Thaler Asset Management, Inc. | 5.69% | SCHEDULE 13G |
| 2026-02-17 | Kornit Digital Ltd. | Granahan Investment Management LLC | 5.67% | SCHEDULE 13G |
| 2026-02-17 | FTAI Infrastructure Inc. | Frontier Capital Management Co.,LLC | 5.65% | SCHEDULE 13G |
| 2026-02-20 | D. Boral Acquisition I Corp. | Sculptor Capital LP | 5.65% | SCHEDULE 13G |
| 2026-02-17 | Ssr Mining Inc. | Global X Management CO LLC | 5.63% | SCHEDULE 13G |
| 2026-02-17 | Stellar Bancorp Inc | North Reef Capital Management LP | 5.62% | SCHEDULE 13G |
| 2026-02-17 | Park Dental Partners, Inc. | Swenson Nicholas John | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Kaiser Aluminum Corp | Nomura Asset Management International Inc. | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Climb Bio, Inc. | MPM BioImpact LLC | 5.6% | SCHEDULE 13G |
| 2026-02-19 | ProCap Acquisition Corp | RP Investment Advisors LP | 5.6% | SCHEDULE 13G |
| 2026-02-20 | Tyra Biosciences Inc | Dapice Joshua J. | 5.6% | SCHEDULE 13G |
| 2026-02-17 | Skyline Builders Group Holding Limited | Philadelphia Financial Management of San Francisco, LLC | 5.59% | SCHEDULE 13G |
| 2026-02-17 | Relmada Therapeutics, Inc. | Spruce Street Capital LP | 5.57% | SCHEDULE 13G |
| 2026-02-17 | StoneX Group Inc | T. Rowe Price Associates, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Masco Corp | Harris Associates L P | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Artivion, Inc. | Nomura Asset Management International Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Surrozen, Inc. | Braidwell LP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Bitcoin Infrastructure Acquisition Corp Ltd | LMR Partners LLP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Rekor Systems, Inc. | Anson Funds Management LP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Mfs Investment Grade Municipal Trust | Almitas Capital LLC | 5.5% | SCHEDULE 13G |
| 2026-02-17 | PPL Corp | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Ingersoll-Rand Inc | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Sportradar Group Ag-A | T. Rowe Price Investment Management, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-19 | Immunic, Inc. | Soleus Capital Master Fund, L.P. | 5.5% | SCHEDULE 13G |
| 2026-02-17 | Blueport Acquisition Ltd | Shaolin Capital Management LLC | 5.49% | SCHEDULE 13G |
| 2026-02-17 | SuperX AI Technology Ltd | Anatole Investment Management Limited | 5.48% | SCHEDULE 13G |
| 2026-02-17 | Andersen Group Inc | Driehaus Capital Management LLC | 5.44% | SCHEDULE 13G |
| 2026-02-17 | ITHAX Acquisition Corp III | Magnetar Financial LLC | 5.43% | SCHEDULE 13G |
| 2026-02-17 | ITHAX Acquisition Corp III | Aristeia Capital, L.L.C. | 5.43% | SCHEDULE 13G |
| 2026-02-17 | Texas Ventures Acquisition III Corp | J. Goldman & Co LP | 5.41% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Fifth Third Bancorp | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pebblebrook Hotel Trust | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Soleno Therapeutics, Inc. | Avoro Capital Advisors LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Crescent Biopharma Inc | Vestal Point Capital, LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | FG Merger II Corp. | Highbridge Capital Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | GigCapital8 Corp. | Lynrock Lake LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Blue Ridge Bankshares, Inc. | Azora Capital LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Spruce Biosciences, Inc. | ADAR1 Capital Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | FTAI Infrastructure Inc. | AllianceBernstein L.P. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Newbridge Acquisition Ltd | Shaolin Capital Management LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Vermilion Energy Inc | Ameriprise Financial, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Quanex Building Products Corporation | Ameriprise Financial, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Ross Berner | 5.4% | SCHEDULE 13G |
| 2026-02-17 | New America Acquisition I Corp. | Weiss Asset Management LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | AN2 Therapeutics, Inc. | Almitas Capital LLC | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Churchill Capital Corp XI | Fort Baker Capital Management LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Pool Corp | T. Rowe Price Investment Management, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Booz Allen Hamilton Holdings | T. Rowe Price Investment Management, Inc. | 5.4% | SCHEDULE 13G |
| 2026-02-19 | Neumora Therapeutics, Inc. | Raymond Debbane | 5.4% | SCHEDULE 13G |
| 2026-02-20 | Netstreit Corp. | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-02-20 | Spartacus Acquisition Corp. II | RP Investment Advisors LP | 5.4% | SCHEDULE 13G |
| 2026-02-17 | Miluna Acquisition Corp | Aristeia Capital, L.L.C. | 5.38% | SCHEDULE 13G |
| 2026-02-17 | A2z Cust2mate Solutions Corp. | Alyeska Investment Group, L.P. | 5.38% | SCHEDULE 13G |
| 2026-02-17 | Energy Recovery, Inc. | Amundi | 5.38% | SCHEDULE 13G |
| 2026-02-17 | Teva Pharmaceutical Industries Ltd. | Migdal Insurance & Financial Holdings Ltd | 5.37% | SCHEDULE 13G |
| 2026-02-17 | Cohen Circle Acquisition Corp. II | Lighthouse Investment Partners, LLC | 5.35% | SCHEDULE 13G |
| 2026-02-17 | Silicon Valley Acquisition Corp. | Magnetar Financial LLC | 5.33% | SCHEDULE 13G |
| 2026-02-17 | Garrett Motion Inc | Fuller & Thaler Asset Management, Inc. | 5.32% | SCHEDULE 13G |
| 2026-02-17 | K2 Capital Acquisition Corp | Shaolin Capital Management LLC | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Ivanhoe Electric Inc | Alyeska Investment Group, L.P. | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Kura Sushi USA Inc. | Hood River Capital Management LLC | 5.31% | SCHEDULE 13G |
| 2026-02-17 | Malibu Boats, Inc. | Nomura Asset Management International Inc. | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Bbb Foods Inc | Orbis Investment Management Ltd | 5.3% | SCHEDULE 13G |
| 2026-02-17 | GRAIL, Inc. | Baker Bros. Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Verastem Inc | Armistice Capital, LLC | 5.3% | SCHEDULE 13G |
| 2026-02-17 | K2 Capital Acquisition Corp | Linden Capital L.P. | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Glaukos Corp | Janus Henderson Group Plc | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Navan, Inc. | Ilan Twig | 5.3% | SCHEDULE 13G |
| 2026-02-18 | Genius Sports Ltd | Senvest Management, LLC | 5.3% | SCHEDULE 13G |
| 2026-02-18 | Cabaletta Bio Inc | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-02-17 | Agios Pharmaceuticals, Inc. | Armistice Capital, LLC | 5.21% | SCHEDULE 13G |
| 2026-02-17 | Clean Harbors Inc | D1 Capital Partners L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Vail Resorts Inc | Oasis Management Co Ltd. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Manhattan Associates Inc | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Marathon Bancorp, Inc. | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Strattec Security Corp | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Uscb Financial Holdings Inc | AllianceBernstein L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Upstart Holdings, INC. | Jericho Capital Asset Management L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Tetra Technologies Inc | Ameriprise Financial, Inc. | 5.2% | SCHEDULE 13G |
| 2026-02-17 | HA Sustainable Infrastructure Capital, Inc. | T. Rowe Price Investment Management, Inc. | 5.2% | SCHEDULE 13G |
| 2026-02-18 | Eikon Therapeutics Inc | Abu Dhabi Investment Authority | 5.2% | SCHEDULE 13G |
| 2026-02-17 | Zeta Global Holdings Corp. | Contour Asset Management LLC | 5.15% | SCHEDULE 13G |
| 2026-02-17 | Lincoln Educational Services Corp | Alyeska Investment Group, L.P. | 5.14% | SCHEDULE 13G |
| 2026-02-17 | TAT Technologies Ltd | Migdal Insurance & Financial Holdings Ltd | 5.13% | SCHEDULE 13G |
| 2026-02-17 | Iron Horse Acquisition II Corp. | Magnetar Financial LLC | 5.11% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Warrior Met Coal Inc | T. Rowe Price Associates, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Flutter Entertainment plc | Parvus Asset Management Jersey Limited | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Arcellx, Inc. | Vestal Point Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Day One Biopharmaceuticals, Inc. | Vestal Point Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Gitlab Inc. | Eminence Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Alpha Cognition Inc. | Manchester Management Company, LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Iron Horse Acquisition II Corp. | LMR Partners LLP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Range Capital Acquisition Corp II | LMR Partners LLP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Camtek Ltd | Migdal Insurance & Financial Holdings Ltd | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Hess Midstream LP | Harvest Fund Advisors LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Kazia Therapeutics Ltd | Ikarian Capital, LLC | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Cardinal Infrastructure Group Inc. (Class A) | Mark McKinney | 5.1% | SCHEDULE 13G |
| 2026-02-17 | DraftKings Inc | Janus Henderson Group Plc | 5.1% | SCHEDULE 13G |
| 2026-02-17 | RadNet, Inc. | RTW Investments, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | American Public Education Inc | No Street GP LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | UMH Properties Inc | T. Rowe Price Investment Management, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Indivior Pharmaceuticals, Inc. | Fuller & Thaler Asset Management, Inc. | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Airsculpt Technologies, Inc. | Parian Ultreia LP | 5.1% | SCHEDULE 13G |
| 2026-02-19 | Alpha Cognition Inc. | Funicular Funds, LP | 5.1% | SCHEDULE 13G |
| 2026-02-17 | Definium Therapeutics Inc | Avoro Capital Advisors LLC | 5.08% | SCHEDULE 13G |
| 2026-02-17 | Restaurant Brands International Inc | EdgePoint Investment Group Inc. | 5.08% | SCHEDULE 13G |
| 2026-02-19 | Psyence Biomedical Ltd. | Weiner Jeffrey David | 5.07% | SCHEDULE 13G |
| 2026-02-17 | Centurion Acquisition Corp. | HGC Investment Management Inc | 5.04% | SCHEDULE 13G |
| 2026-02-17 | Minerals Technologies Inc | Nomura Asset Management International Inc. | 5.03% | SCHEDULE 13G |
| 2026-02-17 | Rambus Inc | T. Rowe Price Associates, Inc. | 5% | SCHEDULE 13G |
| 2026-02-17 | BJ's Restaurants Inc | Woodline Partners LP | 5% | SCHEDULE 13G |
| 2026-02-17 | Taysha Gene Therapies, Inc. | Vestal Point Capital, LP | 5% | SCHEDULE 13G |
| 2026-02-17 | Praxis Precision Medicines Inc. | Orbis Investment Management Ltd | 5% | SCHEDULE 13G |
| 2026-02-17 | Network-1 Technologies, Inc. | Cannell Capital LLC | 5% | SCHEDULE 13G |
| 2026-02-17 | Fifth District Bancorp Inc | AllianceBernstein L.P. | 5% | SCHEDULE 13G |
| 2026-02-17 | Ormat Technologies Inc | Migdal Insurance & Financial Holdings Ltd | 5% | SCHEDULE 13G |
| 2026-02-17 | Brightstar Lottery PLC | Lazard Asset Management LLC | 5% | SCHEDULE 13G |
| 2026-02-19 | Power REIT | Bradley and Daytona Railway and Land Co. LLC | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)431 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.